ARCHIVES

Oral Sorafenib Trial Published in The Lancet; Tablets Extend PFS in Metastatic Disease

This article is from The Cancer Letter archive.

Vol. 37 No. 4 | April 25, 2014

Download PDF Visit The Full Archive

Related Articles

Greenpeace Report Says Chemicals Causing Breast Cancers

October 22, 1993

Enzalutamide Reduced Risk of Progression By 81 Percent in Metastatic Prostate Cancer

June 27, 2014

In Brief: Willis Taylor New ACS President, Gerald Murphy President Elect, Robert Gadberry Bord Chairman

November 19, 1982

Evansvile CCOP Withdrawn, Cites Budget Cut, DR

September 9, 1983

Seer Data On Cancer Incidence Among Minorities Published

May 10, 1996

NCI Plans Preclinical Studies Of Endoxifen, A Tamoxifen Metabolite.

August 7, 2009